Innate Pharma S.A. ADR (IPHA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 156,258 | 227,233 | 179,883 | N/A | N/A |
| Marketable Securities | 16,957 | 17,895 | 17,971 | N/A | N/A |
| Receivables | 24,918 | 20,989 | 179,644 | N/A | N/A |
| TOTAL | $198,133 | $266,118 | $377,498 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 13,358 | 13,073 | 12,065 | N/A | N/A |
| Investments And Advances | 44,474 | 41,446 | 41,549 | 0 | 0 |
| Intangibles | 52,876 | 108,604 | 99,829 | 0 | 0 |
| Other Non-Current Assets | 42,328 | 20,285 | 1,945 | 0 | 0 |
| TOTAL | $153,036 | $183,408 | $155,388 | $N/A | $N/A |
| Total Assets | $351,169 | $449,524 | $532,886 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,447 | 2,386 | 1,591 | N/A | N/A |
| Accounts payable and accrued liabilities | 33,742 | 55,445 | 108,245 | 0 | 0 |
| Other current liabilities | 2,865 | 23,988 | 25,556 | N/A | N/A |
| TOTAL | $51,961 | $136,441 | $232,346 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 19,356 | 18,584 | 3,750 | N/A | N/A |
| Deferred Revenues | 12,907 | 54,622 | 96,955 | N/A | N/A |
| Other Non-Current Liabilities | 56,261 | 4,370 | 17,011 | 0 | 0 |
| TOTAL | $121,036 | $69,578 | $103,028 | $N/A | $N/A |
| Total Liabilities | $172,998 | $206,018 | $335,376 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 4,512 | 4,414 | 3,776 | N/A | N/A |
| Retained earnings | -251,832 | -174,352 | -159,188 | N/A | N/A |
| Other shareholders' equity | 406 | -528 | -1,297 | 0 | 0 |
| TOTAL | $178,171 | $243,506 | $197,510 | $N/A | $N/A |
| Total Liabilities And Equity | $351,169 | $449,524 | $532,886 | $0 | $0 |